Print version of this report
TGA Action ID RC-2025-RN-00418-1
Type of Product Medical Device
Product Name/Description Liquid Assayed Specific Protein Controls. An in vitro diagnostic medical device (IVD).

Liquid Assayed Specific Protein Control L1
Catalog Numbers: PS2682, PS10221

Liquid Assayed Specific Protein Control L2
Catalog Numbers: PS2683, PS10222

Liquid Assayed Specific Protein Control L3
Catalog Numbers: PS2684, PS10223

multiple expiry dates and batch numbers
ARTG Number 199684
Action Type Product Correction
Action Level Hospital
Hazard Classification Class II
Reason for the Action The Rheumatoid Factor (RF) concentrations in Liquid Assayed Specific Protein Controls Level 1 Lots 647LPC and 686LPC are below the measurement range of nephelometric methods on Siemens instruments.

Randox can also confirm that Anti Streptolysin O (ASO) target and range values have been reassigned in lot no’s 706LPC, 707LPC, 708LPC, 709LPC and 710LPC.

They may cause a delay in testing patient samples and/or a delay in reporting patient results.

Investigation is ongoing, Randox Laboratories has removed the associated targets and ranges for RF and reassigned the targets and ranges for ASO. IFU has been updated.
Instructions for Customers/Users Randox Laboratories has reassigned the targets and ranges for ASO and removed the associated targets and ranges for RF.

Customers are to download the updated value sheets and discard the previous version.

This action has been closed out on 29/05/2025
Action Commencement Date 24/04/2025
Responsible Entity Randox Australia Pty Ltd
Contact Information 02 9615 4640 - Randox Australia Office